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“WE CAN’T SOLVE PROBLEMS BY USING 
THE SAME KIND OF THINKING WE USED 










• HCRU & Costs
• Drug Safety
Knowledge • Appropriate Use
• Clinical Management
• Precision Medicine





• Evidence-Based Benefit 
Design
Actions









What can work to 
modify/cure the 
Disease? (Discovery)
• In vitro/ In vivo 
experiments
• Agonists / Antagonists
• Small molecule vs. live 
medicines
• Receptor inhibitors
• DNA Repair (Gene 
therapy)
• MAB, bi-specifics
How does the drug 
work? (MOA)
• Regulating signaling








How well does the 
drug work? (Clinical 
Exp)
• Discovery Clinical 
Trials
• Pivotal Clinical Trials 
(Regulatory) 
• Longitudinal Design







preclinical, translational, Med 
Affairs
Includes: preclinical, 













Drive and inform Disease Area Stronghold strategies including portfolio planning and 
new business development and support key assets
EVIDENCE-GENERATION STRATEGIES – THE SPECTRUM
• Examine and identify 
unmet needs
• Understand the current 
and emerging treatment 
paradigms
• Where and what are the 
care delivery settings?
• Describe key 
characteristics of drug
• Overall clinical profile of 
new Tx
• Identify new and 
meaningful outcomes
• Potential additional 




• Burden of illness
• Quality-of-Life Impacts
• Treatment patterns 
and pathways
• Key patient sub-groups 
• Healthcare Resource 
Utilization
• System and co-technology
barriers
• Payer perspectives –
incidence/prevalence, 
severity, direct costs 
• Key regional variations in 
care 
• Model & establish linkage 
surrogate vs. final endpoints 
• Response / outcomes for 
comparators
• Health Utilities Index (HUI) 
Mode
• Economic modelling – NNT, 
WTP, etc.
• Adherence and appropriate
use, patterns and drivers
• Contemporary clinical 
management
• Patient perspectives – Tx 
satisfaction, preferences, 
caregiver burden
• HCRU gaps and cost offset 
models
• Indirect costs, copays burden, 
etc.
• AMCP Dossiers Economic & 
budget  models




• Actual dosing & tx duration
• Adherence, compliance, 
persistence
• Outcomes vs. surrogates 
• HCRU and costs
• Comparative effectiveness
• Supports
• Market Access Reviews
Explore Accelerate in market growth by reducing uncertainty for national & local payers
Early Development Late Development Pre Launch Post Launch

















































- Variations in care
- Quality metrics
Societal








DRUG DEVELOPMENT / PRODUCT LIFE CYCLE
Drug Discovery, Clinical 
Development
POC        Phase I               Phase II                  Phase III                  Phase IV / PMSS
Drug Discovery, Clinical Development
Medical Affairs / HEOR
Epi, NNT, WTP
Patient Journey
Unmet Need, Study Design, Protocol/SAP, PRO/QoL
development validation, preferences, HCRU
Observational, BOI, 
CEA, GVD, NMA, SDM
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VISION
• To build an integrated cross-functional medical affairs organization that brings value to healthcare providers 
and decision makers, and patients and caregivers through objective and appropriate scientific evidence
MISSION
• Medical Affairs organization will serve as a key function in forming Business Unit(s) and ensuring its success 
both in short- and long-term, and;





























Well Coordinated & 
highly collaborative
Shared Vision, 




Shared Accountability for 
Extraordinary Results





• Integrated planning 
• Therapeutic Area or Molecule level
• Integrate across projects/studies
• Oversee projects
• Design and enhance workflows
• Cross-functional













FROM MARKET ACCESS TO MEDICAL AFFAIRS
TRADITIONAL APPROACH
• Support market access tactics
• Value proposition driven models
• And more models…
• Narrow stakeholder perspective (P&T, PBM, etc.)
• Limited Applicability & Potential (self-serving)
• And even more models…
• Unmet Needs [oxymoron]
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CONTEMPORARY & BOLD
 Medical Affairs-HEOR Bridge
 Highly trained scientists
 Multi-stakeholder perspective (ECHO model)
 Invaluable in shaping the environment
 Well-informed drug discovery programs











Health care costs for employers are rising much faster than inflation. The common approach to health 
benefit design of increasing cost sharing has failed to contain costs. Some employers, however, have 
been successful at mitigating the cost trend or actually reducing health care costs. These employers 
have in common a dedication to data analysis, a search for cost drivers, and a willingness to adjust 
their approach to health benefit design to address these cost drivers. This approach has much in 
common with the movement in clinical practice toward evidence-based medicine. We propose that 
employers adopt a similar approach toward health benefits termed evidence-based benefit design, 
which is based on a health and productivity framework focused on direct and indirect costs. Evidence-
based benefit design incorporates the relevant literature and employer-specific data that are 
integrated and regularly analyzed. 
Champions do extra.
They sweep the sheds.
They follow the spearhead.
They keep a blue head.
heart of how great leaders are - and we 
are all leaders - 'reboot' and reframe 
their future
My Approach to My Profession, Career, and Life in General
https://www.nytimes.com/2017/01/13/jobs/in-choosing-a-job-focus-on-the-fun.html?contentCollection=smarter-living&_r=0
Confidential – internal use only
• "optimal experience" 
• genuinely satisfying
• state of consciousness
• achieve deep enjoyment, creativity, and a total 
involvement with life 
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Complete a graduate certificate in 1 year 
or Master’s degree in 2 years
• 100% online
• Accelerated 7-week courses






| THOMAS JEFFERSON UNIVERSITY  | COLLEGE OF POPULATION HEALTH
Visit our Website 
for more information 
Addressing Social Determinants of Health: Practicalities for 
Healthcare Systems
May 19, 2021 | 12:00 -1:00 pm ET
Register Now 
Women in Health Data Science 
June 2, 2021 | 12:00 -1:00 pm ET
Register Now 

